Results 61 to 70 of about 5,401 (225)
Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis
International Journal of Dermatology, EarlyView.Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller +11 more
wiley +1 more source
Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion
Journal of the European Academy of Dermatology and Venereology, EarlyView.Systematic review of 108 studies with a total of 182 patients with interstitial granulomatous dermatitis (IGD). IGD was frequently associated with systemic conditions or drug exposure. Management includes careful medication review and prompt withdrawal of potential triggers. Corticosteroids (systemic and topical) were commonly effective, while biologic
Francesco Bellinato +4 more
wiley +1 more source
Analysis of pruritus (pimecrolimus vs vehicle).
, 2014 Analysis of pruritus (pimecrolimus vs vehicle).
Youyu Sheng (545451) +1 more
core +1 more source
Педиатрическая фармакология, 2011 Two new topical immunomodulators, pimecrolimus cream and tacrolimus ointment for atopic dermatitis (AD) in pediatric patients, have provided alternatives to topical corticosteroids without the associated adverse events.
S.L. Chen, J. Yan, F.S. Wang
doaj +2 more sources
Clinical Epidemiology, 2018 Background There is a concern that topical tacrolimus and pimecrolimus, indicated for second-line treatment of atopic dermatitis, may increase the risk of lymphoma and skin cancer, particularly in children.
J. Castellsagué +14 more
semanticscholar +1 more source
ChemistrySelect, Volume 11, Issue 33, 1 September 2026.This narrative review analyzes DENV molecular targets, including structural proteins (C, prM/M, E), non‐structural components (NS1NS5), and host factors, alongside small‐molecule candidates in preclinical and clinical phases. Owing to high structural conservation, the NS2B‐NS3 protease and NS5 (RdRp/MTase) remain primary drug discovery focuses, while ...
Aryane Lucia da Silva Aguiar De Oliveira +8 more
wiley +1 more source
Dermatologic Therapy, 2020 Dear Editor, Cutaneous necrosis may be a clinical sign of systemic disorders and the recognition of an underlying disease is mandatory to assess proper therapeutic management.
L. Bianchi +6 more
semanticscholar +1 more source
Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.ABSTRACT Background To synthesize the most current and relevant evidence regarding pruritus management in patients with atopic dermatitis (AD), and to identify implications for nursing assessment, education, monitoring, and follow‐up. Method An extensive literature search was conducted across multiple databases, including the Cochrane Library, Embase ...
Yuzhen Shen +3 more
wiley +1 more source
Pediatric Dermatology, Volume 43, Issue 5, Page 1158-1162, September/October 2026.ABSTRACT Although topical corticosteroids are known triggers in the development of perioral dermatitis (PD), investigation into inhalant and nasal corticosteroid preparations, commonly used to manage allergic rhinitis and asthma, remains limited to case series.
Taylor Merkle +4 more
wiley +1 more source